You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 8, 2025

Details for Patent: 4,839,177


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,839,177
Title: System for the controlled-rate release of active substances
Abstract:A system for the controlled-rate release of active substances, consisting of: (a) a deposit-core comprising the active substance and having defined geometric form; (b) a support-platform applied to said deposit-core. Said deposit-core contains, mixed with the active substance, a polymeric material having a high degree of swelling on contact with water or aqueous liqids, a gellable polymeric material, said polymeric materials being replaceable by a single polymeric material having both swelling and gelling properties, and other adjuvants able to provide the mixture with suitable characteristics for its compression and for its intake of water.
Inventor(s): Colombo; Paolo (Pavia, IT), La Manna; Aldo (Pavia, IT), Conte; Ubaldo (Busto Arsizio, IT)
Assignee: Jagotec AG (Hergiswill, CH)
Application Number:06/939,810
Patent Claim Types:
see list of patent claims
Formulation; Process;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 4,839,177

Introduction

United States Patent 4,839,177, titled "System for the controlled-rate release of active substances," is a significant patent in the field of pharmaceuticals, particularly in controlled drug release systems. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this patent.

Patent Overview

The patent, granted on June 13, 1989, describes a system designed for the controlled-rate release of active substances, such as drugs. This system is crucial in pharmaceuticals as it ensures that the active substance is released at a consistent rate, which can improve the efficacy and safety of the medication[2].

Claims Analysis

The claims of a patent are its most critical components, as they define the scope of the invention and what is protected by the patent.

Independent Claims

The patent includes several independent claims that outline the core aspects of the invention. For example:

  • Claim 1 describes a controlled drug release system comprising an active-containing core particle surrounded by a water-insoluble polymer membrane.
  • Other claims may detail specific components, such as the type of polymer used or the method of preparing the system.

Dependent Claims

Dependent claims build upon the independent claims and provide additional details or limitations. These claims help to narrow down the scope of the invention and can be used to differentiate the patented system from prior art.

Scope of the Patent

The scope of the patent is determined by the claims and their interpretation.

Claim Construction

In legal proceedings, the claims are subject to construction to ascertain their meaning and scope. This process involves a two-step analysis:

  • First, the court must construe the claims to understand their meaning.
  • Second, the court compares the construed claims with the accused infringing product to determine infringement[4].

Prosecution History

The prosecution history of the patent, including interactions with the patent examiner, can provide valuable insights into the scope of the claims. For instance, any amendments made during the prosecution process can affect the interpretation of the claims[4].

Patent Landscape

Understanding the patent landscape is crucial for assessing the value and impact of a patent.

Related Patents

The patent landscape includes other patents related to controlled drug release systems. For example, U.S. Patent No. 4,839,177 has been referenced in later patents and legal cases, indicating its significance in the field. The '177 patent has been used as a reference in infringement analyses and claim constructions for other related patents[4].

Competitors and Market Impact

The value of the patent can also be assessed by looking at similar patents and transactions in the industry. For instance, significant deals involving patent portfolios, such as the $4.5 billion paid by Rockstar Bidco for Nortel's patents, highlight the high value placed on intellectual property in the tech and pharmaceutical sectors[1].

Patent Analytics

To fully understand the scope and claims of the patent, patent analytics can be employed.

Claim Coverage Matrix

A Claim Coverage Matrix can help identify which patents and claims are actively protecting the intellectual property related to the controlled drug release system. This matrix categorizes patents by claims and scope concepts, making it easier to filter, search, and analyze large numbers of patent claims[5].

Claim Charts

Interactive claim charts generated by software like ClaimScape® can be used to review patent coverage with technical experts. These charts help in determining whether a particular scope concept is applicable to a target product or method, highlighting gaps in current coverage and future design opportunities[5].

Legal and Regulatory Considerations

The patent's validity and enforcement are subject to legal and regulatory frameworks.

Infringement Analysis

To prove direct infringement, the patentee must establish that one or more claims of the patent read on the accused device literally or under the doctrine of equivalents. This involves a detailed analysis of the claims and the accused product[4].

Prosecution History and Claim Limitations

The prosecution history, including any amendments and arguments made during the patent application process, informs the court's infringement analysis. This history can clarify the scope of the claims and differentiate them from prior art[4].

Economic Value

The economic value of a patent like U.S. Patent 4,839,177 can be substantial.

Transaction Values

The prices paid for patent portfolios in similar fields can indicate the value of individual patents. For example, the $7.7 million paid for a patent application in 2017 and the $510,204.08 per patent in the Novell and Google-Motorola deals highlight the significant economic value of patents in the tech and pharmaceutical industries[1].

Key Takeaways

  • Claims and Scope: The claims of U.S. Patent 4,839,177 define the controlled drug release system and its components, with independent and dependent claims providing a detailed scope.
  • Patent Landscape: The patent is part of a broader landscape of related patents and has been referenced in various legal cases and transactions.
  • Patent Analytics: Tools like Claim Coverage Matrix and Claim Charts are essential for analyzing and managing patent portfolios.
  • Legal Considerations: Infringement analysis and prosecution history are critical in determining the patent's validity and scope.
  • Economic Value: The patent holds significant economic value, as evidenced by transactions in the industry.

FAQs

Q: What is the main invention described in U.S. Patent 4,839,177? A: The main invention is a system for the controlled-rate release of active substances, such as drugs, using a water-insoluble polymer membrane.

Q: How are the claims of a patent constructed and interpreted? A: Claims are constructed through a two-step analysis involving the court's interpretation of the claims and comparison with the accused infringing product.

Q: What role does the prosecution history play in patent infringement cases? A: The prosecution history informs the court's infringement analysis by clarifying the scope of the claims and differentiating them from prior art.

Q: How can patent analytics tools help in managing patent portfolios? A: Patent analytics tools like Claim Coverage Matrix and Claim Charts help in categorizing patents, identifying gaps in coverage, and highlighting future design opportunities.

Q: What is the economic significance of patents like U.S. Patent 4,839,177? A: Patents in this field can have substantial economic value, as seen in significant transactions involving patent portfolios in the tech and pharmaceutical industries.

Sources

  1. The Value of a Patent - Perpetual Motion Patents
  2. System for the controlled-rate release of active substances - US-4839177-A
  3. Patent Claims Research Dataset - USPTO
  4. IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT - Finnegan
  5. Patent Analytics - SLWIP

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 4,839,177

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 4,839,177

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Italy23321 A/85Dec 20, 1985

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.